- Breaking News San Mateo County ninth-graders struggle to stay fit
- Breaking News Food and wine events
- Breaking News Ask Amy: What To Do When the Doctor Isn t in the House
- Breaking News Ed Blonz: Keep your diet normal pre-surgery
Immunomedics posts positive data of its experimental cancer drug and Medicure meets primary endpoints in Phase II diabetic hypertension study.
0 Comments | M2 Presswire, September, 2005
M2 PRESSWIRE-22 September 2005-US Financial Network: Immunomedics posts positive data of its experimental cancer drug and Medicure meets primary endpoints in Phase II diabetic hypertension study(C)1994-2005 M2 COMMUNICATIONS LTD RDATE:22092005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU) Immunomedics Inc.
(Nasdaq: IMMU) said Wednesday that a German study of its experimental cancer therapy showed that patients taking its drug after surgery lived twice as long as those receiving standard chemotherapy drugs or who went without treatment. The five-year study monitored 19 patients who had surgery to remove spreading cancer from their livers. About half of the group survived through to the end of the period....
- Getting to the root of beautiful hair: shiny, silky hair begins with a healthy scalp - includes list of resources and a recipe for an herbal scalp tonic
- Made from scratch: When Honda built a plant in Alabama it also built a workforce-using local workers who had no experience in making cars - Recruitment & Hiring
- Industry Experts Launch Money Management Resources to Help People Overcome Debt and Learn Proper Money Management Practices
- Portfolio forecasting tools: what you need to know
- Why fly solo when an executive assistant can accelerate your CLNC® business?
- Banking technology, technological learning and competition: comparative case studies in Thai banking
- John Seely Brown Inducted Into 2004 Industry Hall of Fame
- SmartDisk's New VST Flash Media Reader(TM) Reads SmartMedia(TM), CompactFlash(TM) From A Single Desktop Unit